Vulvar Neoplasms

14 registered clinical trials studyying Vulvar Neoplasms — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Danish Vulva Cancer Recurrence Study NCT06495554	University of Aarhus	N/A
Recruiting	Agnostic Therapy in Rare Solid Tumors NCT06638931	Instituto do Cancer do Estado de São Paulo	Phase 2
Recruiting	A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Part NCT05592626	Marengo Therapeutics, Inc.	Phase 1 / Phase 2
Completed	Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid NCT05578820	Gene Surgery LLC	Phase 1
Recruiting	Quality of Life in Patients Undergone Vulvar Reconstruction After Vulvar Cancer Resection (3233) NCT06132321	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Completed	Impact of the COVID-19 Pandemic in Gynecological Oncology NCT04351139	Hospices Civils de Lyon	—
Completed	Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females NCT03546842	Merck Sharp & Dohme LLC	Phase 3
Completed	E7 TCR T Cells for Human Papillomavirus-Associated Cancers NCT02858310	National Cancer Institute (NCI)	Phase 1 / Phase 2
Unknown	HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life NCT03000192	University Hospital Southampton NHS Foundation Trust	—
Completed	Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy NCT02786524	University of Michigan	N/A
Completed	Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology NCT00288821	UMC Utrecht	—
Unknown	Questionnaire Study for Gynecological Cancer Survivors NCT00391664	U.S. Army Medical Research and Development Command	—
Completed	Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage NCT00224744	Institut Claudius Regaud	Phase 3
Completed	Magnetic Resonance Imaging Guided Gynecologic Brachytherapy NCT00112307	Brigham and Women's Hospital	N/A